Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML.
Shaffer BC, Le Luduec JB, Park S, Devlin S, Archer A, Davis E, Cooper C, Nhaissi M, Suri B, Wells D, Tamari R, Papadopoulos E, Jakubowski AA, Giralt S, Hsu KC.
Shaffer BC, et al. Among authors: suri b.
Blood Adv. 2021 Apr 13;5(7):2003-2011. doi: 10.1182/bloodadvances.2020002701.
Blood Adv. 2021.
PMID: 33843984
Free PMC article.